SMAD2 and Hepatic fibrosis: Based on the consistent expression of total Smad2 and Smad3, levels of TGF-β1 and phosphorylated Smad2 and Smad3 were upregulated in the liver fibrosis model, but decreased in the drug group, and the differences were statistically significant.